Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Opioids not key – cartels are diversified

Stewart 17 – Scott, Stratfor analyst of terrorism and security issues. “Mexico's Cartels Will Continue to Splinter in 2017”, Stratfor, https://worldview.stratfor.com/article/mexicos-cartels-will-continue-splinter-2017, 02-02-2017

In my July 13 On Security column about the Mexican government's anti-cartel policy, I discussed how the dynamics of the cocaine trade affected the historical trajectory of Mexican organized crime. In short, cocaine provided cartels with unprecedented quantities of cash that they then parlayed into power. Starting in the 1980s, Mexican criminal organizations began fighting over the immense profit pool produced by the lucrative trade in powder, and this infighting has continued in one form or another to this day. But cocaine was merely the first of several drugs that were game changers for Mexican organized crime groups. The latest of them, fentanyl (and related synthetic opioids), is the most profitable yet, and is rapidly becoming the deadliest drug for users north of the border. Disruptive Drugs Mexican criminals have been incredibly flexible and adaptive in terms of the drugs they supply to the massive illegal narcotics market in the United States. Much of this flexibility naturally comes in response to consumer demand for certain types of drugs. But enforcement and interdiction also heavily influence the activities of Mexican drug-trafficking organizations. Increased disruption of Caribbean cocaine-trafficking routes, for example, led Colombian cartels to rely more heavily on Mexican groups to move their product over land into the United States. This change transformed the Mexicans into a critical link in the cocaine supply chain and allowed figures such as Gulf cartel leader Juan Garcia Abrego to demand larger profit cuts. Methamphetamine is another good example of Mexican cartels recognizing and seizing business opportunities created by market forces and enforcement activity. U.S. law enforcement action targeting industrial-scale methamphetamine labs in California's Central Valley, and state and federal legislation such as the Combat Methamphetamine Epidemic Act of 2005, made it increasingly difficult to manufacture methamphetamine in the United States. Mexican criminal organizations, especially several Sinaloa cartel affiliates, recognized the opportunity presented by these developments and dramatically expanded their methamphetamine production in response. They also improved the quality and purity of the drug, compared to the product made by smaller operations in the United States. As a result, methamphetamine for sale on American streets became better, cheaper and more widely available.

Sign in to recut, update, or save this card.